IPSC
Century Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.86
−1.06%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.11
- Revenue actual
- —
- Revenue estimate
- $2.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +1.0%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.11 | -$0.17 | Miss -54.55% | — |
| May 13, 2026 | -$0.15 | -$0.11 | Beat 26.67% | — |
| Mar 12, 2026 | -$0.29 | -$0.25 | Beat 13.79% | — |
| Nov 13, 2025 | -$0.39 | -$0.32 | Beat 17.95% | — |
| Aug 14, 2025 | -$0.38 | -$0.38 | In line | — |
| May 15, 2025 | -$0.31 | $0.89 | Beat 387.10% | $109.2M |
| Mar 19, 2025 | -$0.45 | -$0.43 | Beat 4.44% | $4.2M |
| Aug 8, 2024 | -$0.50 | -$0.38 | Beat 24.00% | $771.0K |
| May 9, 2024 | -$0.50 | -$0.45 | Beat 10.00% | $855.0K |
| Mar 14, 2024 | -$0.56 | -$0.49 | Beat 12.50% | $268.0K |
| Nov 9, 2023 | -$0.53 | -$0.55 | Miss -3.77% | $148.0K |
| May 11, 2023 | -$0.53 | -$0.53 | In line | $1.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026